{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:14:43Z","timestamp":1783440883598,"version":"3.54.6"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>\n                      To evaluate the accuracy of statistical parametric mapping (SPM) and Scenium in the differential diagnosis of Parkinson disease (PD) and atypical Parkinsonian syndromes based on\n                      <jats:sup>18<\/jats:sup>\n                      F-fluoro-deoxy-glucose (\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG) imaging, and to explore the application of these 2 software programs in analyzing patients with Parkinson disease of varying severity, as well as to construct and evaluate the metabolic profiles of PD patients using Scenium.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A total of 64 patients with Parkinsonian syndrome who met the diagnostic criteria were included in this study. PET images were used for disease diagnosis with SPM and Scenium based on diagnostic charts, and the diagnostic accuracy of both software programs was assessed through consistency analysis. Meanwhile, an in-depth analysis was performed to compare the sensitivity, specificity, positive predictive value, and negative predictive value of the 2 software programs. In addition, Scenium was used to construct a diagnostic model for PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>SPM demonstrated greater accuracy in distinguishing between PD and APS, with a significantly higher Kappa value (K_spm=0.704) compared with Scenium (K_scenium=0.440). The sensitivity and specificity of SPM were 82.5% and 91.7%, respectively. Further, a PD diagnostic model was constructed by incorporating PET parameters from the contralateral central region and basal ganglia, achieving a diagnostic accuracy of 82.9%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>SPM can more accurately differentiate the diagnosis of Parkinson disease from atypical Parkinson syndrome compared with Scenium.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rct.0000000000001763","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T09:00:09Z","timestamp":1750928409000},"page":"978-984","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The Diagnostic Value of 18F-FDG PET in Parkinson Disease Based on Voxel Analysis"],"prefix":"10.1097","volume":"49","author":[{"given":"Bing","family":"Han","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxue","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yipeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8930-3670","authenticated-orcid":false,"given":"Ping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"},{"name":"Heilongjiang Key Laboratory for Accurate Diagnosis and Treatment of Coronary Heart Disease, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"R1-20251111","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J Neurol Neurosur Ps"},{"key":"R2-20251111","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Chal-lenges in the diagnosis of Parkinson\u2019s disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol"},{"key":"R3-20251111","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R4-20251111","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMra2401857","article-title":"Parkinson\u2019s disease","volume":"391","author":"Tanner","year":"2024","journal-title":"N Engl J Med"},{"key":"R5-20251111","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(24)00094-1","article-title":"What next in Parkinson\u2019s disease?","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R6-20251111","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1212\/WNL.0000000000000641","article-title":"Low clinical diagnos-tic ac-curacy of early vs advanced Parkinson disease: clinicopathologic study","volume":"83","author":"Adler","year":"2014","journal-title":"Neurology"},{"key":"R7-20251111","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"R8-20251111","first-page":"61","article-title":"The differential diagnosis and treatment of atypical Parkinsonism","volume":"113","author":"Levin","year":"2016","journal-title":"Dtsch Arztebl Int"},{"key":"R9-20251111","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","article-title":"Parkinson\u2019s disease and Parkinsonism","volume":"132","author":"Hayes","year":"2019","journal-title":"Am J Med"},{"key":"R10-20251111","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1474-4422(10)70002-8","article-title":"Differential diagnosis of Parkinsonism: a metabolic imaging study using pattern analysis","volume":"9","author":"Tang","year":"2010","journal-title":"Lancet Neurol"},{"key":"R11-20251111","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00415-014-7384-x","article-title":"Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study","volume":"261","author":"Jecmenica-Lukic","year":"2014","journal-title":"J Neurol"},{"key":"R12-20251111","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40336-013-0026-y","article-title":"Glucose metabolism in normal aging and Alzheimer\u2019s disease: methodological and physiological considerations for PET studies","volume":"1","author":"Mosconi","year":"2013","journal-title":"Clin Transl Imaging"},{"key":"R13-20251111","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.2967\/jnumed.116.186403","article-title":"18F-FDG PET in Parkinsonism: differential diagnosis and evaluation of cognitive impairment","volume":"58","author":"Meyer","year":"2017","journal-title":"J Nucl Med"},{"key":"R14-20251111","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2967\/jnumed.116.183152","article-title":"Metabolic imaging in Parkinson disease","volume":"58","author":"Meles","year":"2016","journal-title":"J Nucl Med"},{"key":"R15-20251111","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1098\/rstb.1999.0478","article-title":"Statistical limitations in functional neuroimaging. II. Signal detection and statistical inference","volume":"354","author":"Petersson","year":"1999","journal-title":"Philos T R Soc B"},{"key":"R16-20251111","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.neuroimage.2005.03.012","article-title":"FDG PET in the differential diagnosis of Parkinsonian disorders","volume":"26","author":"Eckert","year":"2005","journal-title":"Neuroimage"},{"key":"R17-20251111","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s12149-020-01490-7","article-title":"Brain 18F-FDG PET analysis via interval-valued reconstruction: proof of concept for Alzheimer\u2019s disease diagnosis","volume":"34","author":"Kucharczak","year":"2020","journal-title":"Ann Nucl Med"},{"key":"R18-20251111","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.2967\/jnumed.117.203950","article-title":"Age-specific 18F-FDG image processing pipelines and analysis are essential for individual mapping of seizure foci in pediatric patients with intractable epilepsy","volume":"59","author":"De Blasi","year":"2018","journal-title":"J Nucl Med"},{"key":"R19-20251111","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1007\/s00259-020-04785-z","article-title":"Differential diagnosis of Parkinsonian syndromes: a comparison of clinical and automated\u2014metabolic brain patterns\u2019 based approach","volume":"47","author":"Rus","year":"2020","journal-title":"Eur J Nucl Med Mol I"},{"key":"R20-20251111","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1515\/revneuro-2018-0061","article-title":"Metabolic pattern analysis of 18F-FDG PET as a marker for Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"30","author":"Gu","year":"2019","journal-title":"Rev Neuroscience"},{"key":"R21-20251111","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000345987","article-title":"Neuroimaging markers of motor and nonmotor features of Parkinson\u2019s disease: an 18f fluorodeoxyglucose positron emission computed tomography study","volume":"35","author":"Huang","year":"2013","journal-title":"Dement Geriatr Cogn"},{"issue":"suppl 1","key":"R22-20251111","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/S1353-8020(11)70020-7","article-title":"18F-FDG PET study on the idiopathic Parkinson\u2019s disease from several Parkinsonian-plus syndromes","volume":"18","author":"Zhao","year":"2012","journal-title":"Parkinsonism Relat D"},{"key":"R23-20251111","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/biom13020218","article-title":"Retinal structure abnormalities in Parkinson\u2019s disease and atypical Parkinsonism","volume":"13","author":"Ma","year":"2023","journal-title":"Biomolecules"},{"key":"R24-20251111","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3389\/fneur.2020.572976","article-title":"Neuroimaging advances in Parkinson\u2019s disease and atypical Parkinsonian syndromes","volume":"11","author":"Saeed","year":"2020","journal-title":"Front Neurol"},{"key":"R25-20251111","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1212\/WNL.0000000000005161","article-title":"Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease","volume":"90","author":"Pilotto","year":"2018","journal-title":"Neurology"},{"key":"R26-20251111","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1007\/s10072-022-06166-w","article-title":"FDG PET in the differential diagnosis of degenerative Parkinsonian disorders: usefulness of voxel-based analysis in clinical practice","volume":"43","author":"Arnone","year":"2022","journal-title":"Neurol Sci"},{"key":"R27-20251111","doi-asserted-by":"crossref","first-page":"103475","DOI":"10.1016\/j.nicl.2023.103475","article-title":"Comparison of univariate and multivariat-e analyses for brain [18F]FDG PET data in \u03b1-synucleinopat-hies","volume":"39","author":"Carli","year":"2023","journal-title":"Neuroimage Clin"}],"container-title":["Journal of Computer Assisted Tomography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RCT.0000000000001763","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T20:00:34Z","timestamp":1762891234000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RCT.0000000000001763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rct.0000000000001763","relation":{},"ISSN":["0363-8715","1532-3145"],"issn-type":[{"value":"0363-8715","type":"print"},{"value":"1532-3145","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"assertion":[{"value":"2025-01-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}